Subbaraman Ramnath, Jhaveri Tulip, Nathavitharana Ruvandhi R
Department of Public Health and Community Medicine and Center for Global Public Health, Tufts University School of Medicine, Boston, USA.
Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, USA.
J Clin Tuberc Other Mycobact Dis. 2020 Jan 11;19:100144. doi: 10.1016/j.jctube.2020.100144. eCollection 2020 May.
The care cascade-which evaluates outcomes across stages of patient engagement in a health system-is an important framework for assessing quality of tuberculosis (TB) care. In recent years, there has been progress in measuring care cascades in high TB burden countries; however, there are still shortcomings in our knowledge of how to reduce poor patient outcomes. In this paper, we outline a research agenda for understanding why patients fall through the cracks in the care cascade. The pathway for evidence generation will require new systematic reviews, observational cohort studies, intervention development and testing, and continuous quality improvement initiatives embedded within national TB programs. Certain gaps, such as pretreatment loss to follow-up and post-treatment disease recurrence, should be a priority given a relative paucity of high-quality research to understand and address poor outcomes. Research on interventions to reduce death and loss to follow-up during treatment should move beyond a focus on monitoring (or observation) strategies, to address patient needs including psychosocial and nutritional support. While key research questions vary for each gap, some patient populations may experience disparities across multiple stages of care and should be a priority for research, including men, individuals with a prior treatment history, and individuals with drug-resistant TB. Closing gaps in the care cascade will require investments in a bold and innovative action-oriented research agenda.
关怀级联——评估患者在卫生系统中各个参与阶段的结果——是评估结核病(TB)护理质量的重要框架。近年来,高结核病负担国家在衡量关怀级联方面取得了进展;然而,在如何减少患者不良结局方面,我们的认知仍存在不足。在本文中,我们概述了一项研究议程,以了解患者为何在关怀级联中出现脱节情况。产生证据的途径将需要新的系统评价、观察性队列研究、干预措施的开发与测试,以及纳入国家结核病规划的持续质量改进举措。鉴于了解和解决不良结局的高质量研究相对匮乏,某些差距,如治疗前失访和治疗后疾病复发,应作为优先事项。关于减少治疗期间死亡和失访的干预措施的研究应超越对监测(或观察)策略的关注,以满足患者需求,包括心理社会和营养支持。虽然每个差距的关键研究问题各不相同,但一些患者群体可能在多个护理阶段经历差异,应作为研究重点,包括男性、有既往治疗史的个体以及耐多药结核病患者。缩小关怀级联中的差距将需要对一项大胆且创新的以行动为导向的研究议程进行投资。